Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus Disease”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Not applicableStudy completedNCT05494801
What this trial is testing

Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 203
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 248
Early research (Phase 1)UnknownNCT05301504
What this trial is testing

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 76
Early research (Phase 1)Study completedNCT03428347
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Who this might be right for
Healthy
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Ended earlyNCT02295501
What this trial is testing

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Who this might be right for
Acute Ebola Virus Disease
Cerus Corporation 6
Early research (Phase 1)Study completedNCT02464670
What this trial is testing

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Who this might be right for
Ebola Vaccine
Inovio Pharmaceuticals 240
Not applicableNot Yet RecruitingNCT07681752
What this trial is testing

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA

Who this might be right for
Ebola Hemorrhagic FeverLassa Hemorrhagic Fever
Institute of Tropical Medicine, Belgium 150
Testing effectiveness (Phase 2)UnknownNCT04822376
What this trial is testing

Prophylaxis Vaccine Antibodies Ebola

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 250
Large-scale testing (Phase 3)Looking for participantsNCT06126822
What this trial is testing

Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC

Who this might be right for
Ebola Virus Disease
Institute of Tropical Medicine, Belgium 624
Early research (Phase 1)Study completedNCT02314923
What this trial is testing

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 513
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Testing effectiveness (Phase 2)Study completedNCT02876328
What this trial is testing

Partnership for Research on Ebola VACcinations

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,789
Not applicableStudy completedNCT05313139
What this trial is testing

Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers

Who this might be right for
Immune Response
Institute of Tropical Medicine, Belgium 133
Not applicableStudy completedNCT02658331
What this trial is testing

Evaluation of the FilmArray BioThreat-E Test

Who this might be right for
Ebola Virus Disease
BioMérieux 156
Early research (Phase 1)Study completedNCT02485912
What this trial is testing

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation